Skip to content

Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery

Epidemiology of Peroperative Bleeding and Transfusion During Scheduled Surgery.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02311309
Enrollment
1439
Registered
2014-12-08
Start date
2013-11-30
Completion date
2014-03-31
Last updated
2016-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Loss, Surgery

Brief summary

Peroperative bleeding has been studied in specific populations exposed to bleeding (i.e. cardiac surgery, orthopedic surgery). Epidemiology of peroperative bleeding and transfusion remain poorly studied in the whole cohort of patients scheduled for surgery remain unknown. The investigators conducted a prospective study in order to examine the incidence, and risk factors associated with peroperative bleeding and transfusion.

Detailed description

This was a prospective observational including all consecutive patients scheduled for surgery during a 3 month period. Exclusion criteria were : emergency, cardiac surgery, and pediatric surgery. Patients received an oral information and informed consent was search for all of them. Throughout the study period (3 months) data were prospectively recorded by members of a specific research team not involved in the care of patients. Preoperative, peroperative and immediate postoperative data (post anesthesia care unit) were collected. Unanticipated bleeding was defined as either transfusion above the pre ordered packed red blood cells or hemoglobin concentration \< 8 g/dL.

Interventions

OTHERControl

Control patients were defined as either transfusion using only pre ordered packed red blood cells or peroperative hemoglobin concentration \>8 g/dL.

OTHERUnanticipated bleeding

Unanticipated bleeding was defined as either transfusion above the pre ordered packed red blood cells or peroperative hemoglobin concentration \< 8 g/dL.

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient scheduled for non cardiac and non emergency surgery

Exclusion criteria

* Cardiac surgery * Emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
Unanticipated Bleedingone dayFrom arrival in operating room until the patients leave post anesthesia care unit

Secondary

MeasureTime frameDescription
Preoperative Anemiaone dayproportion of patients with preoperative anemia
Lowest Hemoglobinone daylowest peroperative hemoglobin concentration
Transfusionsone daytransfusion pattern in the whole cohort

Participant flow

Participants by arm

ArmCount
Control
Patients with either transfusion with pre ordered packed red blood cells or hemoglobin concentration \> 8 g/dL. Control: Control patients were defined as either transfusion using only pre ordered packed red blood cells or peroperative hemoglobin concentration \>8 g/dL.
541
Unanticipated Bleeding
Unanticipated bleeding was defined as either transfusion above the pre ordered packed red blood cells or hemoglobin concentration \< 8 g/dL. Unanticipated bleeding: Unanticipated bleeding was defined as either transfusion above the pre ordered packed red blood cells or peroperative hemoglobin concentration \< 8 g/dL.
35
No Peroperative Significant Bleeding
Patients for whom surgery did not result in significant bleeding
863
Total1,439

Baseline characteristics

CharacteristicControlUnanticipated BleedingNo Peroperative Significant BleedingTotal
Age, Continuous59 years
STANDARD_DEVIATION 17
66 years
STANDARD_DEVIATION 16
53 years
STANDARD_DEVIATION 19
56 years
STANDARD_DEVIATION 18
ASA class
ASA Class 1
107 participants2 participants261 participants370 participants
ASA class
ASA Class 2
283 participants18 participants448 participants749 participants
ASA class
ASA Class 3
150 participants14 participants150 participants314 participants
ASA class
ASA Class 4
1 participants1 participants4 participants6 participants
body mass index28 kg/m^2
STANDARD_DEVIATION 6
27 kg/m^2
STANDARD_DEVIATION 6
26 kg/m^2
STANDARD_DEVIATION 6
27 kg/m^2
STANDARD_DEVIATION 6
red blood cell pre-planned (yes/no)
No
368 participants18 participants835 participants1221 participants
red blood cell pre-planned (yes/no)
Yes
173 participants17 participants28 participants218 participants
Sex: Female, Male
Female
254 Participants19 Participants405 Participants678 Participants
Sex: Female, Male
Male
287 Participants16 Participants458 Participants761 Participants
Units of packed red blood cell pre planned (number)3 units of packed red blood cell3 units of packed red blood cell2 units of packed red blood cell3 units of packed red blood cell

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Unanticipated Bleeding

From arrival in operating room until the patients leave post anesthesia care unit

Time frame: one day

ArmMeasureValue (NUMBER)
ControlUnanticipated Bleeding0 percentage of participants
Unanticipated BleedingUnanticipated Bleeding100 percentage of participants
No Significant BleedingUnanticipated Bleeding0 percentage of participants
Secondary

Lowest Hemoglobin

lowest peroperative hemoglobin concentration

Time frame: one day

Secondary

Preoperative Anemia

proportion of patients with preoperative anemia

Time frame: one day

Secondary

Transfusions

transfusion pattern in the whole cohort

Time frame: one day

ArmMeasureGroupValue (NUMBER)
ControlTransfusionstransfusion of pack red blood cell33 number of participants
ControlTransfusionsno transfusion508 number of participants
Unanticipated BleedingTransfusionstransfusion of pack red blood cell31 number of participants
Unanticipated BleedingTransfusionsno transfusion4 number of participants
No Significant BleedingTransfusionstransfusion of pack red blood cell1 number of participants
No Significant BleedingTransfusionsno transfusion862 number of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026